Use of pseudotyped, replication deficient influenza to facilitate testing of gene delivery strategies for treatment of highly infectious diseases

Use of pseudotyped, replication deficient influenza to facilitate testing of gene delivery strategies for treatment of highly infectious diseases

Bibliographic Details
Main Authors:	Tan, T, Rijal, P, Townsend, A, Hyde, S, Gill, D
Format:	Conference item
Published:	Elsevier 2018

Similar Items

Investigating pseudotyped lentiviral vectors for gene delivery to the lung
by: Munday, RJ
Published: (2021)

Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity.
by: Powell, T, et al.
Published: (2012)

In vivo enhancement of tumour-specific T cells via peptide–MHC-pseudotyped retroviral gene delivery
by: Kwong, H, et al.
Published: (2025)

Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors
by: Kandasamy, M, et al.
Published: (2023)

Towards a first-in-human trial with a pseudotyped lentivirus
by: Alton, EW, et al.
Published: (2020)

Characterisation and application of an ebola virus glycoprotein pseudotyped influenza virus (E-S-Flu)
by: Xiao, HJ
Published: (2019)

Lung-targeted lentiviral vector mediates passive immunisation against influenza
by: Tan, T, et al.
Published: (2018)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS IN A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
by: Griesenbach, U, et al.
Published: (2012)

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
by: Griesenbach, U, et al.
Published: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS AS A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
by: Griesenbach, U, et al.
Published: (2012)

Delivery of genes into the CF airway
by: Gill, D, et al.
Published: (2014)

Lung-targeting lentiviral vector for passive immunisation against influenza
by: Tan, TK, et al.
Published: (2020)

431. Lung antibody factory for passive immunisation against influenza
by: Tan, T, et al.
Published: (2016)

Lentiviral-mediated expression of monoclonal antibodies in the lung to protect against influenza
by: Du, Y, et al.
Published: (2020)

Gene therapy for surfactant protein B deficiency using recombinant AAV
by: Meyer-Berg, H, et al.
Published: (2019)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
by: Sergijenko, A, et al.
Published: (2020)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
by: Munday, RJ, et al.
Published: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
by: Munday, RJ, et al.
Published: (2022)

Insertional mutagenesis in zebrafish using a pseudotyped retroviral vector
by: Gaiano, Nicholas R. (Nicholas Roger)
Published: (2008)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
by: Munday, RJ, et al.
Published: (2022)

Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery
by: Segel, Michael, et al.
Published: (2022)

Use of a pseudotyped retoviral vector to accomplish insertional mutagenesis in zebrafish
by: Amsterdam, Adam (Adam Henry), 1967-
Published: (2009)

Model suggesting that replication of influenza virus is regulated by stabilization of replicative intermediates.
by: Vreede, F, et al.
Published: (2004)

Gene delivery for leukemia treatment.
by: Yong, Lin Kin.
Published: (2009)

Genome editing of the liver for treatment of alpha-1 antitrypsin deficiency using homology-independent targeted integration (HITI)
by: Van Haasteren, J, et al.
Published: (2019)

A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
by: Munis, AM, et al.
Published: (2020)

Transcription and replication of the influenza a virus genome.
by: Mikulásová, A, et al.
Published: (2000)

Understanding infectious disease using membrane topography engineering: case studies of membrane remodeling in viral replication and antimicrobial treatment
by: Miao, Xinwen
Published: (2023)

Adaptive targeted infectious disease testing
by: Kasy, M, et al.
Published: (2020)

Adaptive targeted infectious disease testing
by: Kasy, M, et al.
Published: (2020)

A: Treatment and prophylaxis of infectious diseases
by: Agtmael, V, et al.
Published: (2008)

A: Treatment and prophylaxis of infectious diseases
by: Agtmael, V, et al.
Published: (2008)

Liposomes for vaccine delivery against infectious bursal disease in chickens
by: Wahab, Mukminah Sakinah
Published: (2016)

Development of recombinant Adeno-Associated Viral vector (rAAV) for passive immunisation against ebola
by: Tan, T, et al.
Published: (2017)

Structure and function of the influenza virus transcription and replication machinery
by: Fodor, E, et al.
Published: (2019)

The role of nucleoprotein in transcription and replication of the Influenza virus genome
by: Turrell, L
Published: (2015)

A structural understanding of influenza virus genome replication
by: Zhu, Z, et al.
Published: (2022)

Viral and host factors regulating influenza virus replication
by: Nilsson, B
Published: (2017)

Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
by: Davies, L, et al.
Published: (2014)

Transcriptomic profiling facilitates classification of response to influenza challenge.
by: Davenport, E, et al.
Published: (2015)